Healthcare ❯ Pharmaceuticals

Regulatory Affairs

FDA Approvals FDA Drug Approval FDA Approval FDA Guidelines Product Launches FDA Designations Market Access Clinical Research

AbbVie Tops Q1 and Raises 2026 Outlook as Skyrizi and Rinvoq Offset Humira Decline

Strong momentum in newer therapies signals progress in replacing lost Humira sales.

Krystal Biotech Posts Strong Q4 as VYJUVEK Hits $107 Million, Pivots 2026 Growth to Ex‑U.S. Markets

AbbVie Settlements Push U.S. Rinvoq Generics To 2037

FDA Begins Expert Review of Menopause Hormone Therapy Warnings